PETX

Aratana Therapeutics, Inc. Competitors

$13.24
*  
0.34
2.64%
Get PETX Alerts
*Delayed - data as of May 4, 2015  -  Find a broker to begin trading PETX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PETX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Aratana Therapeutics, Inc.

CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Prestige Brand Holdings, Inc.
PBH: NYSE
$ 40.05 0.35 ▲ 363,479 $ 40.15
$ 39.73
$ 45
$ 30.02
30.11 2,093,533,650
Prima BioMed Ltd
PBMD: NASDAQ-GM
$ .5102 -0.03 ▼ 5,883 $ .5199
$ .5101
$ 1.56
$ .50
NE 20,896,261
Progenics Pharmaceuticals Inc.
PGNX: NASDAQ-GS
$ 5.30 0.06 ▲ 635,955 $ 5.49
$ 5.19
$ 7.84
$ 3.1001
530 368,646,800
ProPhase Labs, Inc.
PRPH: NASDAQ-GM
$ 1.29 -0.01 ▼ 6,489 $ 1.33
$ 1.29
$ 2.23
$ 1.21
NE 20,500,680
ProQR Therapeutics N.V.
PRQR: NASDAQ-GM
$ 19.48 0.37 ▲ 38,031 $ 19.64
$ 18.7701
$ 27.60
$ 11.0037
NE 430,274,240
Prothena Corporation plc
PRTA: NASDAQ-GS
$ 34.13 0.48 ▲ 394,901 $ 34.68
$ 33.27
$ 45
$ 16.71
NE 1,047,893,390
Provectus Biopharmaceuticals, Inc.
PVCT: AMEX
$ .8889 0.00 ▲ 155,326 $ .91
$ .885
$ 3.75
$ .30
NE 164,598,502
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 60.84 0.98 ▲ 684,665 $ 61.88
$ 59.20
$ 78.72
$ 14.51
NE 2,044,224,000
Puma Biotechnology Inc
PBYI: NYSE
$ 192.99 4.73 ▲ 317,418 $ 199.13
$ 189.10
$ 279.37
$ 53.63
NE 6,204,049,530
QLT Inc.
QLTI: NASDAQ-GS
$ 3.72 0.04 ▲ 84,854 $ 3.72
$ 3.63
$ 6.68
$ 3.35
NE 190,672,320
Radius Health, Inc.
RDUS: NASDAQ-GM
$ 36.87 0.29 ▲ 439,986 $ 38.64
$ 36.60
$ 51.22
$ 7.46
NE 1,361,424,750
Raptor Pharmaceutical Corp.
RPTP: NASDAQ-GM
$ 9.66 0.01 ▲ 1,117,100 $ 9.965
$ 9.47
$ 12.20
$ 7.12
NE 760,512,480
Receptos, Inc.
RCPT: NASDAQ-GS
$ 153.45 -2.95 ▼ 762,749 $ 159.95
$ 153.07
$ 203.25
$ 24.5345
NE 4,834,595,700
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 9.27 0.53 ▲ 67,813 $ 9.50
$ 8.75
$ 15.4014
$ 2.36
NE 72,343,080
Redhill Biopharma Ltd.
RDHL: NASDAQ-CM
$ 14.57 0.09 ▲ 1,255 $ 14.57
$ 14.50
$ 21
$ 6.89
NE 144,796,660
Regado BioSciences, Inc.
RGDO: NASDAQ-CM
$ 1.21 unch 104,458 $ 1.25
$ 1.18
$ 7.3599
$ .80
NE 40,666,890
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 474.17 3.01 ▲ 592,165 $ 477.73
$ 470.5349
$ 495.50
$ 269.50
154.96 47,722,839,650
Regulus Therapeutics Inc.
RGLS: NASDAQ-GM
$ 13.45 -0.02 ▼ 566,430 $ 14.19
$ 13.34
$ 25.60
$ 5.404
NE 679,453,650
Reliv' International, Inc.
RELV: NASDAQ-GS
$ 1.20 0.01 ▲ 4,798 $ 1.20
$ 1.12
$ 2.2095
$ 1.06
15 15,387,600
Relypsa, Inc.
RLYP: NASDAQ-GS
$ 31.07 0.76 ▲ 454,610 $ 31.95
$ 29.94
$ 42.26
$ 17.60
NE 1,255,756,190
Retrophin, Inc.
RTRX: NASDAQ-GM
$ 23.27 0.46 ▲ 430,860 $ 23.37
$ 22.18
$ 25.99
$ 7.85
NE 775,519,290
Revance Therapeutics, Inc.
RVNC: NASDAQ-GM
$ 20.16 -0.06 ▼ 124,349 $ 20.89
$ 20
$ 34.42
$ 14.02
NE 478,195,200
Rexahn Pharmaceuticals, Inc.
RNN: AMEX
$ .7101 -0.01 ▼ 275,949 $ .72
$ .706
$ 1.05
$ .6501
NE 127,257,021
Rigel Pharmaceuticals, Inc.
RIGL: NASDAQ-GS
$ 4.54 0.03 ▲ 823,739 $ 4.807
$ 4.49
$ 5.20
$ 1.56
NE 399,719,760
Rosetta Genomics Ltd.
ROSG: NASDAQ-CM
$ 3.44 -0.04 ▼ 146,333 $ 3.6399
$ 3.44
$ 5.55
$ 2.07
NE 40,461,280